Microbot Medical Inc. financial data

Symbol
MBOT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
25 Recreation Park Dr Suite 108, Hingham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
STEMCELLS INC (to 11/15/2016), CYTOTHERAPEUTICS INC/DE (to 5/15/2000)
Latest financial report
10-K - Q4 2024 - Mar 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 393 % -4.62%
Debt-to-equity 33.1 % +6.63%
Return On Equity -234 % -42.6%
Return On Assets -176 % -40.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.7M shares +141%
Common Stock, Shares, Outstanding 19.4M shares +65.7%
Entity Public Float 15.9M USD -58.3%
Common Stock, Value, Issued 195K USD +65.3%
Weighted Average Number of Shares Outstanding, Basic 15.6M shares +53.4%
Weighted Average Number of Shares Outstanding, Diluted 15.6M shares +53.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.63M USD +15.8%
General and Administrative Expense 5M USD +20.9%
Operating Income (Loss) -11.6M USD -18%
Net Income (Loss) Attributable to Parent -11.4M USD -6.55%
Earnings Per Share, Basic -0.73 USD/shares +30.5%
Earnings Per Share, Diluted -0.73 USD/shares +30.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.11M USD +26.2%
Marketable Securities, Current 2.36M USD -39.9%
Cash, Cash Equivalents, and Short-term Investments 5.47M USD -14.3%
Other Assets, Current 1.34M USD
Assets, Current 5.82M USD -26.5%
Property, Plant and Equipment, Net 80K USD -45.2%
Operating Lease, Right-of-Use Asset 132K USD -49.2%
Assets 6.03M USD -27.6%
Accounts Payable, Current 246K USD +3.36%
Employee-related Liabilities, Current 1.41M USD +94.3%
Accrued Liabilities, Current 2.23M USD +117%
Liabilities, Current 2.46M USD -35%
Operating Lease, Liability, Noncurrent 41K USD +2.5%
Liabilities 2.5M USD -34.6%
Retained Earnings (Accumulated Deficit) -90.9M USD -14.4%
Stockholders' Equity Attributable to Parent 3.53M USD -21.6%
Liabilities and Equity 6.03M USD -27.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.42M USD +24.4%
Net Cash Provided by (Used in) Financing Activities 2.4M USD
Net Cash Provided by (Used in) Investing Activities -1.28M USD -145%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 19.4M shares +65.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.31M USD -308%
Interest Paid, Excluding Capitalized Interest, Operating Activities 40K USD +14.3%
Deferred Tax Assets, Valuation Allowance 118M USD +2.03%
Deferred Tax Assets, Gross 118M USD +1.75%
Operating Lease, Liability 111K USD -51.9%
Payments to Acquire Property, Plant, and Equipment 14K USD
Lessee, Operating Lease, Liability, to be Paid 117K USD -57.8%
Property, Plant and Equipment, Gross 664K USD +3.91%
Operating Lease, Liability, Current 70K USD -63.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 42K USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 75K USD -63.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -87.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21K USD +950%
Deferred Tax Assets, Operating Loss Carryforwards 118M USD +2.19%
Operating Lease, Payments 75K USD -19.4%
Depreciation, Depletion and Amortization 28K USD +12%
Deferred Tax Assets, Net of Valuation Allowance 30K USD -91.6%